262 related articles for article (PubMed ID: 22682645)
1. sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
Lundgren J; Kylhammar D; Hedelin P; Rådegran G
Acta Physiol (Oxf); 2012 Nov; 206(3):178-94. PubMed ID: 22682645
[TBL] [Abstract][Full Text] [Related]
2. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
Hedelin P; Kylhammar D; Rådegran G
Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
[TBL] [Abstract][Full Text] [Related]
3. Role of endothelin receptor activation in secondary pulmonary hypertension in awake swine after myocardial infarction.
Houweling B; Merkus D; Sorop O; Boomsma F; Duncker DJ
J Physiol; 2006 Jul; 574(Pt 2):615-26. PubMed ID: 16709643
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model.
Wiklund A; Kylhammar D; Rådegran G
J Cardiovasc Pharmacol; 2012 May; 59(5):441-9. PubMed ID: 22240915
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 inhibition and thromboxane A(2) receptor antagonism attenuate hypoxic pulmonary vasoconstriction in a porcine model.
Kylhammar D; Rådegran G
Acta Physiol (Oxf); 2012 Aug; 205(4):507-19. PubMed ID: 22554045
[TBL] [Abstract][Full Text] [Related]
6. Effects of the dual endothelin receptor antagonist tezosentan and hypertonic saline/dextran on porcine endotoxin shock.
Somell A; Weitzberg E; Suneson A; Sollevi A; Hjelmqvist H
Acta Physiol (Oxf); 2007 Aug; 190(4):291-302. PubMed ID: 17498196
[TBL] [Abstract][Full Text] [Related]
7. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock.
Konrad D; Oldner A; Rossi P; Wanecek M; Rudehill A; Weitzberg E
Crit Care Med; 2004 May; 32(5):1192-9. PubMed ID: 15190972
[TBL] [Abstract][Full Text] [Related]
8. Acute cardiopulmonary effects of a dual-endothelin receptor antagonist on oleic acid-induced pulmonary arterial hypertension in dogs.
Wang L; Zhu DM; Su X; Bai CX; Ware LB; Matthay MA
Exp Lung Res; 2004; 30(1):31-42. PubMed ID: 14967602
[TBL] [Abstract][Full Text] [Related]
9. Tezosentan decreases pulmonary artery pressure and improves survival rate in an animal model of meconium aspiration.
Geiger R; Pajk W; Neu N; Maier S; Kleinsasser A; Fratz S; Navarro-Psiha S; Fischer V; Treml B; Loeckinger A
Pediatr Res; 2006 Jan; 59(1):147-50. PubMed ID: 16327003
[TBL] [Abstract][Full Text] [Related]
10. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
11. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR
Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195
[TBL] [Abstract][Full Text] [Related]
12. Effect of clazosentan, a selective endothelin A receptor antagonist, and tezosentan, a dual endothelin A/B antagonist, on pulsatile shear stress induced constriction of the iliac in the anaesthetized pig.
Ruane-O'Hora T; Rae MG; Markos F
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):515-20. PubMed ID: 21575033
[TBL] [Abstract][Full Text] [Related]
13. Endothelin infusion reduces hypoxic pulmonary hypertension in pigs in vivo.
Liska J; Holm P; Owall A; Franco-Cereceda A
Acta Physiol Scand; 1995 Aug; 154(4):489-98. PubMed ID: 7484175
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary vascular reserve during experimental pulmonary embolism: effects of a soluble guanylate cyclase stimulator, BAY 41-8543.
Watts JA; Gellar MA; Fulkerson MB; Kline JA
Crit Care Med; 2011 Dec; 39(12):2700-4. PubMed ID: 21705882
[TBL] [Abstract][Full Text] [Related]
15. P2Y₁ and P2Y₁₂ receptors in hypoxia- and adenosine diphosphate-induced pulmonary vasoconstriction in vivo in the pig.
Kylhammar D; Bune LT; Rådegran G
Eur J Appl Physiol; 2014 Sep; 114(9):1995-2006. PubMed ID: 24929904
[TBL] [Abstract][Full Text] [Related]
16. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
[TBL] [Abstract][Full Text] [Related]
17. Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep.
Kuklin VN; Kirov MY; Evgenov OV; Sovershaev MA; Sjöberg J; Kirova SS; Bjertnaes LJ
Crit Care Med; 2004 Mar; 32(3):766-73. PubMed ID: 15090960
[TBL] [Abstract][Full Text] [Related]
18. Effects of endothelin receptor antagonism on acute lung injury induced by chlorine gas.
Wang J; Oldner A; Winskog C; Edston E; Walther SM
Crit Care Med; 2006 Jun; 34(6):1731-7. PubMed ID: 16625121
[TBL] [Abstract][Full Text] [Related]
19. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
Holm P
Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
[TBL] [Abstract][Full Text] [Related]
20. Inhaled tezosentan reduces pulmonary hypertension in endotoxin-induced lung injury.
Persson BP; Rossi P; Weitzberg E; Oldner A
Shock; 2009 Oct; 32(4):427-34. PubMed ID: 19197226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
